Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®
1 other identifier
observational
200
1 country
17
Brief Summary
The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops using connected device CONNECTDROP® The main questions it aims to answer are:
- The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient
- The adherence profile of each patient
- The association between the adherence profile, the objective adherence data and the clinical data. Participants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
17 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 19, 2025
CompletedFirst Submitted
Initial submission to the registry
September 26, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
November 17, 2025
November 1, 2025
12 months
September 26, 2025
November 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops in EASYGRIP® bottle clipped with CONNECTDROP®
Assessment of the mean annual adherence rate, defined as the percentage of the prescribed doses actually taken by the patient (i.e. at least 2 instillations per day).
From enrollment to the end of the study at 12 months
Study Arms (1)
Group receiving T9060 CONNECTDROP
Eligibility Criteria
Glaucoma patients from hospital and/or private practice
You may qualify if:
- Adult patient (≥ 18 years old), man or woman
- Patient with a diagnosis of bilateral open angle glaucoma
- Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy.
- Patient willing to participate in the study
- Patient who consents for data collection in the frame of the study
You may not qualify if:
- Pregnant and/or lactating woman
- Patient receiving another ocular treatment for a chronic condition (i.e. regular instillations for several months)
- Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (17)
Besomed SRLS
Bari, Italy
Studio Oculistico D'Azeglio
Bologna, Italy
Centro Medico Polispecialistico Di Maita
Catania, Italy
Studio Medico Oculistico Dr.ssa Rosa SCHIAVELLI s.r.l.
Corigliano, Italy
Ospedale Policlinico S. Martino-IRCCS Clinica Oculistica Università di Genova
Genova, Italy
Poliambulatorio Chirurgico Modenese Eyecare Clinic
Modena, Italy
Centro Oculistico Ramovecchi S.r.l.
Morrovalle, 62010, Italy
AOU Federico II di Napoli Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche Università degli studi di Napoli Federico II U.O.C. di Oftalmologia
Napoli, Italy
Azienda Ospedale-Università Padova Ospedale Sant'Antonio UOC Oculistica
Padua, Italy
A.O.U. Pisana UO Oculistica Universitaria
Pisa, Italy
Ambulatorio Oculistica Ospedale San Carlo di Nancy -GVM-
Roma, 00165, Italy
Fondazione PTV Policlinico Tor Vergata Fondazione PTV Policlinico Tor Vergata UOSD di Oculistica
Roma, Italy
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS Presidio Ospedaliero Britannico Unità di Ricerca "Glaucoma
Roma, Italy
AULSS 4 Veneto Orientale Ospedale di San Donà di Piave Dip. Oculistica
San Donà di Piave, Italy
AOU Sassari Clinica Oculistica
Sassari, Italy
Studi Oculistici
Seravezza, Italy
Humanitas Gradenigo U.O. Oculistica
Torino, Italy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2025
First Posted
October 3, 2025
Study Start
September 19, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
November 17, 2025
Record last verified: 2025-11